Grand Pharmaceutical Group Limited Financial Overview
Grand Pharmaceutical Group Limited's market cap is currently HK$28.68B. The company's EPS TTM is HK$0.334; its P/E ratio is 13.61; and it has a dividend yield of 3.13%. Grand Pharmaceutical Group Limited is scheduled to report earnings on August 19, 2025, and the estimated EPS forecast is HK$―. See an overview of income statement, balance sheet, and cash flow financials.
